Trend

QS Research · Michael Burry's Scion Capital analyst template · 2006

Glass House Brands Inc. (GLAS)

As of 2026-11-21 · 11/15 boxes filled from SEC filings and market data

Report price $1.18 (close 2026-11-20)

Conclusion: PASS

Conviction low · base case none · downside -50% · upside +42%

At $1.18 the market is pricing Glass House at 0.90x FY Dec 2025 EV/Sales with negative GAAP EBITDA of -$1.5M and a -13.3% FCF yield, so scale is not yet converting into earnings power, margin or cash generation. The call is PASS because the risk is not compensated without an anchor: there is no base case, since no comparable peer multiple sets one and the company’s own history gives none, so a base at today’s multiple is today’s price by construction. The downside is -50.2% to $0.59, from -25.0% sales at a compressed EV/Sales of 0.77x (today 0.9x); the upside is +41.5% to $1.67, from +30% sales at today’s EV/Sales of 0.9x. With the downside larger than the upside and the operating trend still unproven at the margin and cash-flow line, the risk is not compensated.

Key numbers

  • Share price: $1.18
  • Market cap: $118.1M
  • Latest financial period: FY Dec 2025 to Dec 31, 2025
  • Revenue (FY Dec 2025): $182.0M
  • FCF yield: -13.3%
  • Price / book: 1.60x
  • Earnings-quality flags (FY Dec 2025): none flagged
  • Revenue growth (latest fiscal year): -9.4%
  • ROIC (FY Dec 2025): -10.9%

The 15 boxes

  1. ✓ 1. Long-form business notes

    Glass House is a vertically integrated California cannabis company that sells wholesale biomass, wholesale CPG and retail; it filed earlier as Mercer Park Brand Acquisition Corp. until 2021-03-30. The latest full-year anchor in these sources is FY2025: revenue $181.984M, gross profit $77.0M, operating income -$16.5M and net income to common -$45.1M, so operating and net results were not profitable despite positive gross profit. The business has shifted to post-deal scale after the 2021-2022 SoCal, PLUS and NHC transactions, with cultivation expansion continuing into Greenhouse 2 in Q4 2025/2026, while FY2025 revenue was below FY2024's $200.898M.

  2. ✓ 2. Competitive advantage

    Glass House's claimed advantage is scale: vertical integration plus cultivation capacity that went from roughly 332,000 sq ft to ~1,525,000 sq ft in Q2 2024 and ~1,708,000 sq ft in Q4 2025, into a licensed California market where mixed-light/outdoor licences fell by over 4,000 (56%) between June 30, 2022 and December 31, 2024. That is a cost/scale position in a commodity, not a pricing-power position: bulk biomass prices can run as much as 20% lower in the second half than the first, and FY2025 revenue fell to $182.0M from $200.9M with gross profit down to $77.0M from $97.4M and operating income swinging to -$16.5M from +$5.7M. The six years to FY2025 produced no positive net income to common. It competes with licensed retailers and delivery operators, other brand manufacturers bidding for shelf space, and the illicit market including illegal dispensaries.

  3. ✓ 3. 10-Q takeaways

    Q3 2026 revenue rose sharply to $56.794M from $47.017M in Q2 2026 and $26.189M in Q3 2025, led by wholesale biomass at $50.0M; gross margin was 26%, down from 34% in Q2 but up from 21% a year earlier. GAAP results remain loss-making: Q3 2026 operating loss was $(8.666)M and net loss $(10.098)M, while Adjusted EBITDA was positive $0.779M. Cash, restricted cash and equivalents were $39.7M at Sep 30 2026, inventory was $32.928M, and the release reaffirmed FY2026 biomass output of about 1M pounds and a $95/lb long-term cost target.

  4. ○ 4. Corporate governance
  5. ✓ 5. Overview of the prior 3 years of 8-K filings

    Filled; members read this box.

  6. ✓ 6. Other significant filings

    Filled; members read this box.

  7. ✓ 7. Chronology of significant news and events

    Filled; members read this box.

  8. ✓ 8. Comparables valuation interpretation

    Filled; members read this box.

  9. ○ 9. Insider trading interpretation
  10. ○ 10. Earnings-call notes
  11. ✓ 11. Impression of the shareholder letter

    Filled; members read this box.

  12. ○ 12. Scuttlebutt overview
  13. ✓ 13. Valuation and risk/reward summary

    Filled; members read this box.

  14. ✓ 14. Current price suppression and potential catalysts

    Filled; members read this box.

  15. ✓ 15. Conclusions

    The call above.

Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.

Put these signals to work

The Scion template's preview is free. Paid members read every box of every report. FST, the QuantSignals trading agent, uses QS Research as its brain.

Join freeMeet FSTSee plans